You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | -98.5% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -0.4 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 1.2 | n/a |
Price / Book value | 3.2 |
Latest | Forecast | |
---|---|---|
Revenue | -39.5% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2020-03-31 | 3.90 | -1.07 | -3.20p | -29.7 | 0.0 | n/a | n/a | 0.0% |
2021-03-31 | 4.16 | -1.26 | -0.12p | -1,364.4 | 0.0 | n/a | n/a | 0.0% |
2022-03-31 | 4.80 | -1.33 | -4.60p | -13.0 | 0.0 | n/a | n/a | 0.0% |
2023-03-31 | 2.90 | -2.86 | -10.00p | -3.8 | 0.0 | n/a | n/a | 0.0% |
Fusion Antibodies gets first order under new services agreement Sharecast News | 27 Feb |
---|---|
Fusion Antibodies raises £1.38m as it seeks new customers Sharecast News | 14 Feb |
Fusion Antibodies confirms £0.28m tax credit Sharecast News | 01 Feb |
Change of auditor | 16-Apr-24 07:01 |
---|---|
Contract to develop a bespoke OptiPhage library | 15-Apr-24 20:43 |
Block admission six monthly return | 03-Apr-24 00:00 |
Total Voting Rights | 28-Mar-24 17:00 |
Holding(s) in Company | 11-Mar-24 15:26 |